{"id":"https://openalex.org/W7130656013","doi":"https://doi.org/10.1177/08971900261428900","title":"Pharmacist Perspectives on High-Dose Methotrexate Management and Acute Kidney Injury Risk Mitigation in Patients With Lymphoma: Results From a National Survey","display_name":"Pharmacist Perspectives on High-Dose Methotrexate Management and Acute Kidney Injury Risk Mitigation in Patients With Lymphoma: Results From a National Survey","publication_year":2026,"publication_date":"2026-02-20","ids":{"openalex":"https://openalex.org/W7130656013","doi":"https://doi.org/10.1177/08971900261428900","pmid":"https://pubmed.ncbi.nlm.nih.gov/41718528"},"language":"en","primary_location":{"id":"doi:10.1177/08971900261428900","doi":"https://doi.org/10.1177/08971900261428900","is_oa":false,"landing_page_url":"https://doi.org/10.1177/08971900261428900","pdf_url":null,"source":{"id":"https://openalex.org/S182535935","display_name":"Journal of Pharmacy Practice","issn_l":"0897-1900","issn":["0897-1900","1531-1937"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Elizabeth B. King","orcid":"https://orcid.org/0000-0002-9692-2653","observed_orcids":["https://orcid.org/0000-0002-9692-2653"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Elizabeth B. King","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":"https://orcid.org/0000-0002-9692-2653","affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040076242","display_name":"Mikhaila L. Rice","orcid":"https://orcid.org/0000-0002-4273-5780","observed_orcids":["https://orcid.org/0000-0002-4273-5780"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikhaila L. Rice","raw_affiliation_strings":["Cleveland Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021015910","display_name":"Huong L. Truong","orcid":"https://orcid.org/0000-0002-2775-8749","observed_orcids":["https://orcid.org/0000-0002-2775-8749"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huong L. Truong","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082369679","display_name":"Kristin Cole","orcid":"https://orcid.org/0000-0001-5543-5341","observed_orcids":["https://orcid.org/0000-0001-5543-5341"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin C. Cole","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040329994","display_name":"Erin Frazee Barreto","orcid":"https://orcid.org/0000-0002-0996-1487","observed_orcids":["https://orcid.org/0000-0002-0996-1487"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin F. Barreto","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":"https://orcid.org/0000-0002-0996-1487","affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027814648","display_name":"Urshila Durani","orcid":"https://orcid.org/0000-0003-1860-2424","observed_orcids":["https://orcid.org/0000-0003-1860-2424"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Urshila Durani","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075456418","display_name":"Arushi Khurana","orcid":"https://orcid.org/0000-0001-5645-0949","observed_orcids":["https://orcid.org/0000-0001-5645-0949"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arushi Khurana","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sandra M. Herrmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra M. Herrmann","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016853434","display_name":"Nelson Leung","orcid":"https://orcid.org/0000-0002-5651-1411","observed_orcids":["https://orcid.org/0000-0002-5651-1411"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nelson Leung","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019575449","display_name":"Thomas E. Witzig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E. Witzig","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038835015","display_name":"Jason N. Barreto","orcid":"https://orcid.org/0000-0003-2146-5766","observed_orcids":["https://orcid.org/0000-0003-2146-5766"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason N. Barreto","raw_affiliation_strings":["Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09821016,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"8971900261428900","last_page":"8971900261428900"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.6753000020980835,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.6753000020980835,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.14579999446868896,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.053199999034404755,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":1.0},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9139999747276306},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.972000002861023},{"id":"https://openalex.org/keywords/pharmacists-perceptions","display_name":"pharmacist perceptions","score":0.515999972820282},{"id":"https://openalex.org/keywords/creatinine-clearance-estimation","display_name":"creatinine clearance estimation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cockcroft-gault-equation","display_name":"Cockcroft-Gault formula","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cystatin-c","display_name":"cystatin C","score":0.7239999771118164},{"id":"https://openalex.org/keywords/glucarpidase","display_name":"glucarpidase","score":0.843999981880188},{"id":"https://openalex.org/keywords/prehydration","display_name":"prehydration","score":0.6240000128746033},{"id":"https://openalex.org/keywords/renal-function-monitoring","display_name":"renal function monitoring","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9782999753952026},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.5419999957084656},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4880000054836273},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.4641000032424927},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.46209999918937683},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.3871000111103058},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3783000111579895},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.373199999332428},{"id":"https://openalex.org/C2779457091","wikidata":"https://www.wikidata.org/wiki/Q105186","display_name":"Pharmacist","level":3,"score":0.3693999946117401},{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.36329999566078186},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35690000653266907},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.34459999203681946},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34389999508857727},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.310699999332428},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.30730000138282776},{"id":"https://openalex.org/C2777267654","wikidata":"https://www.wikidata.org/wiki/Q3519023","display_name":"Test (biology)","level":2,"score":0.2689000070095062},{"id":"https://openalex.org/C32896092","wikidata":"https://www.wikidata.org/wiki/Q189447","display_name":"Risk management","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.2669999897480011},{"id":"https://openalex.org/C2779548226","wikidata":"https://www.wikidata.org/wiki/Q413243","display_name":"Cystatin C","level":3,"score":0.2526000142097473}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/08971900261428900","doi":"https://doi.org/10.1177/08971900261428900","is_oa":false,"landing_page_url":"https://doi.org/10.1177/08971900261428900","pdf_url":null,"source":{"id":"https://openalex.org/S182535935","display_name":"Journal of Pharmacy Practice","issn_l":"0897-1900","issn":["0897-1900","1531-1937"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:41718528","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41718528","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy practice","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G213118816","display_name":null,"funder_award_id":"UL1-TR002377","funder_id":"https://openalex.org/F4320316438","funder_display_name":"Georgia Clinical and Translational Science Alliance"}],"funders":[{"id":"https://openalex.org/F4320316438","display_name":"Georgia Clinical and Translational Science Alliance","ror":"https://ror.org/034hw7m59"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W1568033114","https://openalex.org/W1930171769","https://openalex.org/W1945834901","https://openalex.org/W1965076953","https://openalex.org/W1983519632","https://openalex.org/W2028038779","https://openalex.org/W2028367795","https://openalex.org/W2036789134","https://openalex.org/W2086338003","https://openalex.org/W2089242301","https://openalex.org/W2110520204","https://openalex.org/W2118829194","https://openalex.org/W2493103431","https://openalex.org/W2612564265","https://openalex.org/W2766169840","https://openalex.org/W2900732897","https://openalex.org/W2985531547","https://openalex.org/W3032984305","https://openalex.org/W3118369645","https://openalex.org/W3133678905","https://openalex.org/W3134889021","https://openalex.org/W3190150908","https://openalex.org/W3195663180","https://openalex.org/W3200821335","https://openalex.org/W3201595862","https://openalex.org/W3205245967","https://openalex.org/W4211121297","https://openalex.org/W4220698194","https://openalex.org/W4220800085","https://openalex.org/W4229773532","https://openalex.org/W4306249846","https://openalex.org/W4323568228","https://openalex.org/W4388419306","https://openalex.org/W4390632393","https://openalex.org/W4392151535","https://openalex.org/W4399428966","https://openalex.org/W4403077125","https://openalex.org/W4404474108","https://openalex.org/W4406899244","https://openalex.org/W4413944207"],"related_works":[],"abstract_inverted_index":{"A":[0,89],"summary":[1],"of":[2,12,26,36,48,91,139,179],"pharmacist-based":[3],"practices":[4,33,53,244],"and":[5,10,54,80,102,125,149,170,177,193,216,227,245],"preferences":[6],"regarding":[7],"the":[8,27,86,116,136,228,248],"prevention":[9],"management":[11,35,250],"high-dose":[13],"methotrexate":[14],"(HDMTX)":[15],"toxicity":[16],"in":[17,195,242],"patients":[18,252],"with":[19,64,132,203,253],"lymphoma":[20,254],"does":[21],"not":[22],"exist.":[23],"The":[24,109],"objective":[25],"study":[28],"was":[29,40,115,200,213,231],"to":[30,51,121,225,233],"describe":[31],"current":[32],"surrounding":[34],"HDMTX":[37,58,127,133,162,167,196,210,256],"therapy.":[38,211,257],"This":[39],"done":[41],"through":[42],"a":[43,156,223],"self-administered,":[44],"web-based,":[45],"cross-sectional":[46],"survey":[47],"hematology/oncology":[49],"pharmacists":[50,93],"ascertain":[52],"individual":[55],"attitudes":[56],"about":[57,247],"therapy":[59,134,197],"management.":[60,198],"Responses":[61],"were":[62,69],"summarized":[63],"descriptive":[65],"statistics.":[66],"Response":[67],"comparisons":[68],"made":[70],"using":[71],"Chi-square":[72],"or":[73,141,145],"Fisher's":[74],"exact":[75],"test":[76,82],"for":[77,83,107,155,251],"categorical":[78],"data,":[79],"Kruskal-Wallis":[81],"variables":[84],"on":[85],"Likert":[87],"scale.":[88],"total":[90],"175":[92],"provided":[94],"116":[95],"eligible":[96],"surveys":[97],"[68":[98],"(59%)":[99],"complete":[100],"responses":[101],"48":[103],"(41%)":[104],"partial":[105],"responses]":[106],"analysis.":[108],"Cockcroft-Gault":[110],"estimated":[111],"creatinine":[112],"clearance":[113],"formula":[114],"most":[117],"preferred":[118],"method":[119],"(61%)":[120],"estimate":[122],"kidney":[123,172],"function":[124,173],"determine":[126],"dosing.":[128],"Respondents":[129,182],"would":[130],"proceed":[131],"until":[135],"predicted":[137,158],"risk":[138,160],"AKI,":[140],"AKI":[142,159],"stage":[143],"2":[144],"3,":[146],"exceeded":[147],"50%":[148],"20%,":[150],"respectively.":[151],"Preferred":[152],"treatment":[153],"modifications":[154],"high":[157],"after":[161],"exposure":[163],"included":[164],"additional":[165],"prehydration,":[166],"dose":[168,230],"reduction,":[169],"increased":[171],"monitoring,":[174],"although":[175],"levels":[176],"degrees":[178],"agreement":[180],"varied.":[181],"indicated":[183],"that":[184],"serum":[185],"cystatin":[186],"C-based":[187],"GFR":[188],"estimates":[189],"lacked":[190],"evidence,":[191],"accuracy,":[192],"practicality":[194],"There":[199],"limited":[201],"familiarity":[202],"cell":[204],"cycle":[205],"arrest":[206],"biomarker":[207],"use":[208],"during":[209],"Glucarpidase":[212],"considered":[214],"time-sensitive":[215],"highly":[217],"effective;":[218],"however,":[219],"acquisition":[220],"cost":[221],"represented":[222],"barrier":[224],"use,":[226],"optimal":[229,249],"felt":[232],"be":[234],"unknown.":[235],"In":[236],"conclusion,":[237],"there":[238],"is":[239],"significant":[240],"heterogeneity":[241],"supportive":[243],"beliefs":[246],"receiving":[255]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-02-20T00:00:00"}